Recently, the ASIC1 expression was found in melanoma and non-melanocytic skin cancers [16], but the ASIC1 role in melanoma progression, as well as the possibility of ASIC1 targeting by selective inhibitors as a new therapeutic strategy for melanoma therapy were not investigated yet. Here, ASIC1 is linked to melanoma.